Complete versus incomplete revascularization in patients with multivessel disease undergoing percutaneous coronary intervention with drug‐eluting stents
- 16 June 2008
- journal article
- research article
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 72 (4) , 448-456
Abstract
Objectives: To investigate the long‐term prognostic implications of complete versus incomplete revascularization in multivessel coronary artery disease (MVD) patients undergoing percutaneous coronary intervention (PCI) with drug‐eluting stent (DES).Background: Coronary artery bypass grafting (CABG) in patients with MVD provides better outcomes when complete revascularization is achieved. There is a paucity of data on the outcomes of complete versus incomplete revascularization of MVD patients undergoing PCI, and currently there is no data available with DES.Methods: Patients with MVD undergoing PCI with DES (sirolimus‐ or paclitaxel‐eluting stent) were included. Comparisons of long‐term outcomes between completely versus incompletely revascularized patients were made. The primary outcome measure was the composite of cardiac death, nonfatal myocardial infarction (MI), or any revascularization. Secondary endpoints were the components of the composite endpoint.Results: A total of 508 patients were considered for this analysis: 212 (41.7%) and 296 (58.3%) had complete and incomplete revascularization, respectively. The median follow‐up was 27.0 (interquartile range: 23.0–37.1) months. After adjusting for baseline characteristics, the hazard ratio (HR, 95% confidence interval) for complete revascularization was 0.43 (0.29–0.63,P< 0.0001) for the primary composite endpoint. Complete revascularization was associated with better outcomes for components of the composite endpoint: 0.37 (0.15–0.92,P= 0.03) for cardiac death, 0.34 (0.16–0.75P= 0.008) for the composite of cardiac death or MI and 0.45 (0.29–0.69,P= 0.0003) for any repeat revascularization. This association was confirmed in a propensity‐matched population.Conclusions: Complete revascularization with DES of MVD patients is associated with lower rates of long‐term adverse events.Keywords
This publication has 20 references indexed in Scilit:
- Impact of Completeness of Percutaneous Coronary Intervention Revascularization on Long-Term Outcomes in the Stent EraCirculation, 2006
- Association between completeness of percutaneous coronary revascularization and postprocedure outcomesAmerican Heart Journal, 2005
- In the current era, complete revascularization improves survival after coronary artery bypass surgeryThe Journal of Thoracic and Cardiovascular Surgery, 2005
- What constitutes optimal surgical revascularization?JACC, 2002
- The effect of completeness of revascularization on event-free survival at one year in the arts trialJACC, 2002
- Influence of Pre-PTCA Strategy and Initial PTCA Result in Patients With Multivessel DiseaseCirculation, 1999
- Long-term outcome of patients with incomplete vs complete revascularization after multivessel PTCA A report from the NHLBI PTCA RegistryEuropean Heart Journal, 1998
- Effect of completeness of revascularization on long-term outcome of patients with three-vessel disease undergoing coronary artery bypass surgery. A report from the Coronary Artery Surgery Study (CASS) Registry.Circulation, 1992
- Importance of complete revascularization in performance of the coronary bypass operationThe American Journal of Cardiology, 1983
- Long-term results following coronary bypass operationThe Journal of Thoracic and Cardiovascular Surgery, 1981